Cost-effectiveness analysis of an enzyme immunioassay (EIA) for the surveillance of arboviruses was conducted. The EIA was compared with conventional virus isolation and serologic identification procedures (virus isolation procedures; VIP). Under most circumstances, EIA was more cost-effective than VIP. Costs for processing mosquito pools by VIP increased with the number of viruses included in the surveillance program and with the prevalence rate of each virus. In contrast to VIP, the prevalence rate did not affect costs for processing pools by EIA. In general, EIA was the most cost-effective procedure, followed by cell culture and mouse bioassays. In a 5-year cost-effectiveness analysis of a model surveillance program in which EIA and cell culture bioassays were used, the EIA again proved to be the most cost-effective assay procedure under most circumstances.
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Enzyme immunoassays (EIAs) have found wide applicability in virus diagnosis and surveillance (18, 21) . The development of EIA procedures is typically justified on the basis of the reduced time and expense that are necessary to obtain diagnostic results in comparison with conventional virus isolation' and identification procedures. The ability of EIAs to provide rapid, clinically relevant diagnostic results has been well documented (2, 4, 10) . However, there is little information concerning the relative cost-effectiveness of EIA and conventional diagnostic procedures (S. W. Hildreth, Ph.D. dissertation, Yale University, New Haven, Conn., 1984).
Previous studies have documented the diagnostic efficacy of a capture antigen EIA for La Crosse encephalitis virus, eastern equine encephalitis virus, and Highlands J virus (6-9; Hildreth, Ph.D. dissertation). The EIA proved to be a sensitive and specific alternative for the surveillance of eastern equine encephalitis and Highlands J viruses (8) . However, expense is also a major factor in judging the utility of a diagnostic procedure. Thus, the EIA procedure was compared with conventional virus isolation and subsequent identification procedures in a cost-effectiveness analysis (CEA).
MATERIALS AND METHODS
EIA. The EIA procedure and materials used for the cost analysis have been reported previously (7, 9; Hildreth, Ph.D. dissertation). The EIA provided diagnostic results in much less time than the virus isolation procedures (VIPs); however, this time that was saved was not included in cost calculations as money that was saved.
VIPs. Two general VIPs were considered: the suckling mouse bioassay and cell culture bioassays. For CEA each bioassay was partitioned into primary virus isolation with amplification and serologic identification of the isolated viruses. For CEA it was assumed that the suckling mouse bioassay was performed following standard procedures (14) . For the cell culture procedures, the basic costs of virus isolation with different culture vessel types and sizes were examined. Two general methods for virus isolation were selected for the cost model (11, 14) . In the first method, mosquito pools were inoculated onto cell cultures with a fluid culture medium. Cultures were observed daily for 5 to 7 days for cytopathic effects. In the second method, a semisolid, agar-based culture medium was used; this restricted the cytopathic effect to discrete plaques. The cost for preparing continuous cell cultures (Vero or BHK-21 cells) did not differ significantly from that for primary cell cultures (chick embryos); the average cost was used. All suspect infected mice or cell cultures were assumed to be passed for virus amplification and serologic identification by the complement fixation (CF) test (14) .
CEA procedure. For the CEA of the EIA and bioassays, general procedures were followed (13, 15 (14) . The procedure yielded about 300 ml of ascitic fluid, at a total cost of $255.43. For the subsequent production of MIAFs the remaining virus stock and nonpregnant mice were used at an anticipated cost of $168.01 per 300 ml of MIAF.
Rabbit antibodies were produced by using purified viruses. Standard procedures (7, 9) were followed for virus purification, and for the cost model four infected roller bottle cell cultures were required. The cost of labor (senior technician) and supplies was calculated to be $106.80 for 5.0 ml of virus stock. Rabbits were inoculated subcutaneously twice with purified virus-Freund adjuvant; all inoculations and bleedings were assigned to a junior technician. By assuming a yield of approximately 85 ml, the cost of this serum sample was $258.51.
Immunoglobulins were precipitated from MIAFs and serum samples by using saturated ammonium sulfate (7, 9) . The cost of buffers, reagents, dialysis tubing, and labor (junior technician) was $27.87 per sample. Immunoglobulin G (IgG) was separated from the saturated ammonium sulfate product by either protein A affinity chromatography or DEAE Affi-Gel Blue (Bio-Rad Laboratories, Richmond, Calif.) affinity chromatography (7, 9) . The total cost of labor (junior technician) plus reagents and supplies was estimated to be $75.57 for a final product of 10 mg of IgG. For the analyses, all enzyme conjugates were obtained from commercial sources. The EIA used in phase I analysis was a qualitative EIA; thereefore, the cost of an automated plate reader was not included.
Cost assumed for the suckling mouse bioassay procedure. A 10% nonfertilized rate or nonspecific death rate was assumed for the pregnant mice. It was assumed that approximately 40 pools per hour could be processed by a junior technician. The cost of inoculation of a mosquito pool into a litter of mice and observation for 10 days was estimated to be $9.07 per pool.
Assumptions for serologic identification. Virus isolates were identified by the CF test. The following assumptions were made about the procedure. (i) Every virus was tested against three different MIAFs for each arbovirus that the surveillance program attempted to monitor, (ii) positive control antigens were included for each of the controls, (iii) each virus isolate was tested at fourfold dilutions against fourfold dilutions of the MIAF, and (iv) the CF test was performed by a senior technician. Costs of reagents and disposable plastic microplates were estimated at $0.15 and $0.14 per 16 wells, respectively. The labor time for the CF test was calculated for two different testing schedules: once a week for 12 weeks and once at the end of 12 weeks. These values were then averaged.
Assumptions for the 5-year surveillance program analysis.
By using the cost estimates from phase T, the 5-year model was constructed with the present values of the net costs for the EIA. These net costs were estimated by discounting all monies spent throughout the 5-year model to their theoretical worth in year 1 of the program. The formula used to discount yearly expenditures was as follows: the 5-year total net cost was divided by the total number of mosquito pools that were tested, resulting in the cost per mosquito pool. The procedure that produced the lowest cost per mosquito pool was considered the most cost-effective method. For the initial model, the surveillance program was assumed to require the testing of N = 1,000 mosquito pools for V = 1 with P = 1% of the pools tested. All costs for supplies, reagents, and labor were assumed to increase yearly by a 7% inflation increment. The discount rate was chosen to be 10%. All equipment costs for the 5-year surveillance program were budgeted for the first year. Additional analyses (15; Hildreth, Ph.D. dissertation) were conducted by varying N (1,000 to 4,000 pools), P (1 to 30%), V (1 to 4 viruses), and the discount rate (5 to 15%); however, only representative results are presented.
The general cost-effectiveness ratios were adjusted to account for the diagnostic value of each assay by using the probability of false-negative [Pr cost-effectiveness ratio per mosquito pool
where a is the test false-positive rate, and ,B is the test false-negative rate. If the assay were 100% accurate, the cost estimate would not be inflated. The method was adjusted for the probability that the assay results were correct for a given prevalence rate of virus.
RESULTS
Costs of performing the EIA were estimated by totaling the costs of reagents, labor, and supplies that were needed to test mosquito pools that originated from surveillance programs that varied by N, P, and V. To simplify these estimates, N was assumed to be 1,000, 2,000, 4,000, or 8,000 mosquito pools. Labor costs were calculated by assuming that N was tested over 12 weeks. P was assumed to be 1, 5, or 10%. V was assumed to be 1, 2, 3, or 4 different viruses. An example of the cost calculations was as follows: N = 1,000 mosquito pools tested over a 12-week period (84 pools per week); 84 pools required 6 plates at $7.92 per plate ($6.12 for reagents plus $1.80 for the plate). Labor costs were $98.48 (senior technician, 8 h), with a total cost of $1.74 per mosquito pool.
The cost estimated to process a mosquito pool by EIA ranged from $1.27 to $5.94, depending on the variables N and V (Table 1 ). The P value did not affect the cost of performing the EIA, because the assay simultaneously de-VOL. 25, 1987 on September 20, 2017 by guest http://jcm.asm.org/ tected and identified specific viral antigens in each pool. However, this same attractive feature of the EIA increased costs when each pool was tested for more than one virus ( Table 1 ). The magnitude of the increase was greatest for the low-volume surveillance program (N = 1,000). This was not unexpected because reagents costs were the greatest for such a program. The cost for the suckling mouse bioassay included the cost for primary isolation, passage, and serologic identification of the virus isolate. Frequently, primary virus isolations had to be repassaged to ensure a characteristic survival pattern of inoculated mice and to produce sufficient viral antigen for serologic identification. The number of pools requiring passage was directly related to the prevalence rate of viruses in the mosquito population and to nonspecific death rates in mouse litters. Costs for passage of the virus isolates were calculated for P values of 1 to 30% (Table 2 ). For P = 1%, the increased cost was estimated to be $0.09 per mosquito pool. However, with P = 10 and 30%, the additional costs per mosquito pool were estimated to be $0.91 and $2.72, respectively. For a surveillance program characterized by N = 1,000 and P = 1 to 30%, the total cost of performing the suckling mouse bioassay was estimated to be between $9.36 and $15.52 per mosquito pool, depending on V (Table 2) . Similarly, with surveillance programs with N = 4,000, the cost per mosquito pool was calculated to be $9.24 to $15.58.
In contrast to the EIA, the cost associated with the suckling mouse bioassay was affected by P as well as by N and V. However, the major expense (e.g., 59 to 98%) was attributable to the initial VIP.
Several examples of cell culture bioassays were included in the cost model. The culture systems varied by the source of cells, the culture vessels, and the type of culture medium identification. The six-well culture plate system was also relatively inexpensive ( For the 5-year CEA model, surveillance programs were required to purchase equipment, depending on the method that was used for evaluating the EIA results. Qualitative evaluation of the EIA was performed by visual scoring (-to +4) of substrate degradation products and did not require instrumentation. Quantitative evaluation of the EIA required a spectrophotometric plate reader (cost, $13,000). Each surveillance program in which the EIA was used was also assigned the purchase of a semiautomatic plate washer (cost, $2,250) and two multichannel pipets (total cost, $800). The total equipment costs for the quantitative and qualitative EIAs were $16,060 and $3,060, respectively. The surveillance program in which cell culture bioassays were used required the following eqipment: large incubator, microscope, isolation hood, and a roller drum (total cost, $12,300).
The results of the CEA were expressed as the ratio of the total cost of the 5-year program (in currently valued monies) per total number of mosquito pools tested, yielding the cost per mosquito pool tested. For the initial parameters of the surveillance program (N = 1,000, P = 1%, V = 1, and discount rate of 10%), the cost of the use of the EIA was $2.26 per mosquito pool when it was tested with the qualitative system and $4.86 per mosquito pool when it was tested with the quantitative system ( Table 4 ). The cost of the use of the suckling mouse bioassay or cell culture was $8.86 and $4.51 per mosquito pool tested, respectively ( Table 5 ). The qualitative EIA was the most cost-effective, followed by the single cell culture test tube procedure and then the quantitative EIA.
Sensitivity analyses revealed several salient characteristics of the three assays. First, when 1,000 mosquito pools were tested for a single virus, the qualitative EIA was always the most cost-effective diagnostic procedure, regardless of the P value of the infected pools and the theorized discount rate. The quantitative EIA was always more cost-effective than the suckling mouse bioassay. However, the P value was required to be 10% before the quantitative EIA became more cost-effective than the single cell culture test tube assay. Second, when V = 3, the single cell culture test tube assay was the most cost-effective, except when the prevalence rate was 10%. However, it is unlikely that a single cell culture test tube assay would be used for detecting three different viruses; at least two different cell lines would be more realistic. Under these alternate conditions and by using the same test protocols, the costs of the cell culture assays were expected to be equal to or greater than $6.54 to $8.47 per mosquito pool (data not shown), which were substantially more than the qualitative EIA ($4.65 to $5.52 per mosquito pool). The suckling mouse bioassay was the least cost-effective assay, regardless of the P value and the discount rate.
The total costs for all assays declined when N was increased to 4,000. Furthermore, the difference in cost between the quantitative and the qualitative EIAs was found to decrease. With V = 1 and N = 4,000, the EIA was again found to be the most cost-effective method ($1.34 to $2.18 per pool), regardless of the value of P and the discount rate. Even with V = 3, the EIA was the most cost-effective assay, particularly when cell culture viral susceptibility was considered. The suckling mouse bioassay was again the least cost-effective.
The diagnostic value of each assay was considered in the final CEA of the EIA. The diagnostic value was the ability of each assay to correctly diagnose both virus-containing pools and normal noninfected mosquito pools (i.e., sensitivity and specificity rates). The sensitivity rates of the EIA and the cell culture assay were estimated previously (6, 7, 9; Hildreth, Ph.D. dissertation) for assaying mosquitoes during the early and late phases of infection. During the early phase of infection, the EIA was assigned sensitivity and specificity rates of 0.418 and 1.0, respectively. During the late phase of infection, the sensitivity and specificity rates of both assays were expected to be 1.0 (or very close to 1.0). For this CEA model, when error rates were corrected for mosquitoes that were assayed in the early phase of infection, the EIA was predicted to be more cost-effective than the cell culture methods when V = 1 (Table 6 ). When V = 3 the EIA was only superior to the cell culture method when two cell culture assays were used per mosquito pool and was only 
DISCUSSION
New diagnostic assays must not only be evaluated by their sensitivity and specificity characteristics but also by the economics of performing them. Recently, several medical diagnostic procedures have been evaluated economically, and the most cost-efficient use of the procedures have been defined (17) . Virus diagnostic methods have not been formally evaluated in this manner. Economic analyses have been applied to arboviruses, but only to the evaluation of epidemics and control of vectors (1, 5, 12, 19) , revealing that routine surveillance and vector control can be less expensive than the cost of a major epidemic. A substantial proportion of the expense of vector surveillance or of a vector control evaluation program is the cost of monitoring the virus within mosquito populations.
The economic analyses demonstrate that the EIA is a cost-effective surveillance diagnostic tool. The cost of the EIA is directly correlated with the number of viruses that are monitored in the surveillance program. Cost is not correlated with the prevalence rate of the virus in the sampled mosquito population. These two characteristics are to be expected from an assay that is designed to measure only a single factor within a specimen. In contrast, bioassays, such as suckling mice and cell culture bioassays, use biologic amplification procedures to separate specimens containing infectious agents from specimens lacking such agents. Subsequently, serologic assays are used to identify the agents. Due to the two-level screening process, the cost of performing such bioassays is influenced by the prevalence rate. Furthermore, the cost is also influenced by the susceptibility range of these bioassays to different arboviruses. For example, two different cell lines may be required when attempting to isolate two or more different viruses from a mosquito pool. Therefore, the number of viruses that are monitored may influence both the cost of virus isolation and the serologic identification procedure.
The cost analysis (phase I) ranked the EIA, cell culture assays, and the suckling mouse bioassay in order of cost-effectiveness. These differences between the first two assays may be underestimated. First, the cost of performing the cell culture bioassay would increase if other serologic assays, such as hemagglutination inhibition or neutralization, were substituted for the CF test or were used to further identify the virus. Second, each mosquito pool may need to be tested by using multiple cell lines.
The use of the 5-year surveillance program model (phase Il cost analysis) allows for a more realistic comparison of different diagnostic methods, regardless of how and when the costs are accrued. In general, CEA is a useful tool in aiding program planners (13, 15, 20) However, the probability of sampling infected mosquitoes during this early phase of infection is low (6,7; Hildreth, Ph.D. dissertation). As such, the effect of the error rates of the EIA on the diagnostic quality of the assay results is minimal when both the overall low prevalence rate of all infected pools and the sensitivity and specificity rates of the EIA are considered.
For these economic analyses, the CEA method was chosen instead of the benefit-cost analysis method. The major difference between the two methods is that a monetary value is assigned to the benefit, which is done in the benefit-cost analysis (15, 20 VIPs. In conclusion, the results of this study indicate that the EIA is a potentially powerful public health surveillance tool. The EIA procedure should be applicable for monitoring any pathogen in a vector population. The EIA provides results rapidly, reliably, and inexpensively; all are features of a diagnostic assay that will be useful not only as a population surveillance tool but also as a standard research tool for many laboratories.
